1. R. B. Raffa, E. Friderichs, W. Reimann, R. P. Shank, E. E. Codd, and J. L. Vaught. Opioid and nonopioid components independently contribute to the mechanism of action of tramadol, an ‘atypical’ opioid analgesic. J Pharmacol Exp Ther 260:275–285 (1992).
2. H. H. Hennies, E. Friderichs, and J. Schneider. Receptor binding, analgesic and antitussive potency of tramadol and other selected opioids. Arzneimittelforschung 38:877–880 (1988).
3. M. C. Frink, H. H. Hennies, W. Englberger, M. Haurand, and B. Wilffert. Influence of tramadol on neurotransmitter systems of the rat brain. Arzneimittelforschung 46:1029–1036 (1996).
4. M. J. Garrido, M. Valle, M. A. Campanero, R. Calvo, and I. F. Troconiz. Modeling of the in vivo antinociceptive interaction between an opioid agonist, (+)-O-desmethyltramadol, and a monoamine reuptake inhibitor, (-)-O-desmethyltramadol, in rats. J Pharmacol Exp Ther 295:352–359 (2000).
5. B. Driessen, W. Reimann, and H. Giertz. Effects of the central analgesic tramadol on the uptake and release of noradrenaline and dopamine in vitro. Br J Pharmacol 108:806–811 (1993).